Gene ontology (%) | Accession no. | Description | Ratio |
---|---|---|---|
Cellular metabolism (31.6%) | NM_030965 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | 3943.41 |
 | NM_022969 | fibroblast growth factor receptor 2 | 684.03 |
 | AU152837 | Sal-like 1 (Drosophila) | 312.29 |
 | NM_007287 | membrane metallo-endopeptidase | 73.38 |
 | BF589322 | R-spondin 3 homolog (Xenopus laevis) | 70.16 |
Signal transduction (17.8%) | NM_001200 | bone morphogenetic protein 2 | 68.96 |
 | NM_000710 | bradykinin receptor B1 | 48.96 |
 | R72286 | microfibrillar-associated protein 4 | 32.40 |
 | NM_004114 | fibroblast growth factor 13 | 28.15 |
 | BE218107 | EPH receptor A5 | 25.68 |
Transcription factor (11.5%) | AJ277914 | LIM homeobox 9 | 25.01 |
 | NM_001452 | forkhead box F2 | 18.08 |
 | AA705845 | transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) | 17.16 |
 | BG261252 | ecotropic viral integration site 1 | 11.58 |
 | NM_020327 | activin A receptor, type IB | 9.32 |
Protein modification (7.9%) | AF245505 | matrix-remodelling associated 5 | 57.89 |
 | AA725644 | ubiquitin specific peptidase 42 | 18.73 |
 | NM_001982 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 11.34 |
 | AV727260 | protein tyrosine phosphatase, receptor type, D | 10.93 |
 | NM_002570 | proprotein convertase subtilisin/kexin type 6 | 9.83 |
Cell differentiation (6.2%) | NM_000641 | interleukin 11 | 17.51 |
 | BC006454 | growth arrest-specific 7 | 15.20 |
 | M69148 | midkine (neurite growth-promoting factor 2) | 14.03 |
 | NM_003991 | endothelin receptor type B | 10.85 |
 | AI758962 | EPH receptor A4 | 7.15 |
Cell adhesion (5.9%) | NM_001999 | fibrillin 2 | 1035.17 |
 | NM_014893 | neuroligin 4, Y-linked | 68.62 |
 | AI694562 | collagen, type IV, alpha 3 | 22.21 |
 | NM_005864 | embryonal Fyn-associated substrate | 8.44 |
 | AU146651 | collagen, type XII, alpha 1 | 4.89 |
Cell cycle (5.9%) | NM_014059 | chromosome 13 open reading frame 15 | 28.40 |
 | M19701 | retinoblastoma 1 (including osteosarcoma) | 4.93 |
 | NM_002009 | fibroblast growth factor 7 | 4.44 |
 | NM_014703 | Vpr (HIV-1) binding protein | 3.92 |
 | AI983033 | DEAD/H box polypeptide 12 | 3.91 |
Cell motility (4.7%) | NM_002784 | pregnancy specific beta-1-glycoprotein 9 | 69.22 |
 | X99268 | twist homolog 1 | 5.45 |
 | NM_015180 | spectrin repeat containing, nuclear envelope 2 | 3.81 |
 | AI990816 | laminin, alpha 1 | 3.59 |
 | N90777 | neuropilin 2 | 3.57 |
Cell proliferation (4.5%) | NM_016931 | NADPH oxidase 4 | 5.79 |
 | AF064826 | glypican 4 | 4.31 |
 | NM_004525 | low density lipoprotein-related protein 2 | 3.85 |
 | NM_001963 | epidermal growth factor (beta-urogastrone) | 3.70 |
 | AF064103 | CDC14 cell division cycle 14 homolog A | 3.67 |
Apoptosis (4.0%) | NM_006850 | interleukin 24 | 25.27 |
 | NM_002135 | nuclear receptor subfamily 4, group A, member 1 | 5.48 |
 | NM_003823 | tumor necrosis factor receptor superfamily | 4.59 |
 | AJ301610 | glutamate receptor, ionotropic, kainate 2 | 3.92 |
 | NM_005809 | peroxiredoxin 2 | 3.90 |